Breztri 160/7.2/5 Mcg 120 Dose

Breztri 160/7.2/5 Mcg 120 Dose Is A Pressurized Inhalation Aerosol Combination Used To Manage Respiratory Conditions Such As Chronic Obstructive Pulmonary Disease (Copd) And Asthma. This Medication Combines Three Active Ingredients In A Single Inhaler To Provide Optimal Control Of Airway Inflammation, Bronchoconstriction, And Mucus Production. Breztri Works By Combining The Effects Of Budesonide, Formoterol, And Glycopyrronium, Which Target Different Pathways Involved In Inflammation And Bronchial Constriction. This Ensures Comprehensive Management Of Breathing Difficulties Associated With Obstructive Airway Diseases. Active Ingredients: Budesonide 160 Mcg: A Corticosteroid That Reduces Inflammation In The Airways. Formoterol 7.2 Mcg: A Long-Acting Beta-Agonist (Laba) That Relaxes The Muscles In The Airways To Allow Easier Airflow. Glycopyrronium 5 Mcg: A Long-Acting Muscarinic Antagonist (Lama) That Helps Reduce Mucus Production And Prevent Airway Constriction. Side Effects: Common Side Effects May Include: Tremor Or Shakiness. Headache. Cough Or Throat Irritation. Dry Mouth. Palpitations. Nervousness Or Restlessness. Less Common Side Effects May Include Severe Bronchospasm, Systemic Corticosteroid Effects (With Long-Term Use), And Infections. Contact A Healthcare Provider If Any Severe Reactions Are Noticed. Precautions: Use Only As Directed By A Healthcare Provider. Not Recommended For Use During Pregnancy Unless Clearly Necessary. Do Not Use As A Rescue Inhaler For Sudden Breathing Problems. Assess For Risk Factors That May Predispose Individuals To Side Effects, Especially In Those With Heart Disease Or Infections. Monitor For Potential Systemic Effects Of Corticosteroids During Long-Term Use. Always Inform Your Healthcare Provider About Any Other Medications You Are Taking To Avoid Drug Interactions.